
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.30 | 2.30 | 0.00 |
Shares | 97.70 | 97.70 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.07 | 19.61 |
Price to Book | 4.33 | 4.44 |
Price to Sales | 1.54 | 2.56 |
Price to Cash Flow | 15.67 | 17.29 |
Dividend Yield | 1.52 | 1.10 |
5 Years Earnings Growth | 10.83 | 12.14 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.76 | 99.64 |
Consumer Defensive | 0.13 | 0.45 |
Financial Services | 0.05 | 0.56 |
Industrials | 0.04 | 0.04 |
Technology | 0.01 | 0.17 |
Number of long holdings: 416
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 11.95 | 818.02 | -2.61% | |
UnitedHealth | US91324P1021 | 7.03 | 425.33 | -6.34% | |
AbbVie | US00287Y1091 | 5.36 | 170.16 | -1.64% | |
J&J | US4781601046 | 4.76 | 156.92 | -0.35% | |
Abbott Labs | US0028241000 | 3.85 | 129.89 | -0.83% | |
Merck&Co | US58933Y1055 | 3.58 | 77.85 | -0.19% | |
Intuitive Surgical | US46120E6023 | 3.28 | 468.32 | -2.99% | |
Thermo Fisher Scientific | US8835561023 | 3.25 | 421.85 | -1.32% | |
Amgen | US0311621009 | 2.66 | 273.68 | -1.30% | |
Boston Scientific | US1011371077 | 2.46 | 93.58 | -1.62% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 690.61B | -4.82 | 8.12 | - | ||
Vanguard 500 Index Admiral | 533.44B | -4.28 | 9.02 | 12.46 | ||
Vanguard Total Stock Market Admiral | 381.66B | -4.83 | 8.10 | 11.74 | ||
Vanguard Total Intl Stock Index Inv | 210.14B | 5.46 | 4.59 | 5.14 | ||
Vanguard 500 Index Institutional Se | 194.95B | -4.28 | 9.05 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review